Clinical Trial Update: Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lubiprostone with maintenance therapy to prevent postoperative recurrence in peritoneal metastatic colorectal cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Metastasis

Drugs mentioned

• Amitiza (lubiprostone)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer Metastatic, Peritoneal (Metastatic) Cancer | Phase 2 | Status: NOT_YET_RECRUITING